BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27165293)

  • 1. Do African-American men need separate prostate cancer screening guidelines?
    Shenoy D; Packianathan S; Chen AM; Vijayakumar S
    BMC Urol; 2016 May; 16(1):19. PubMed ID: 27165293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective.
    Reddy A; Roberts R; Shenoy D; Packianathan S; Giri S; Vijayakumar S
    J Natl Med Assoc; 2020 Oct; 112(5):448-453. PubMed ID: 30409717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of clinically significant prostate cancer in African Americans increased significantly following the 2012 US Preventative Services Task Force recommendation against prostate specific antigen screening: A Single Institution Retrospective Study.
    Arace J; Flores V; Monaghan T; Robins D; Karanikolas N; Winer A; Weiss J
    Int J Clin Pract; 2020 Feb; 74(2):e13447. PubMed ID: 31750596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.
    Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
    NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
    Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
    Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-patient discussions with african american men about prostate cancer screening.
    Ross LE; Powe BD; Taylor YJ; Howard DL
    Am J Mens Health; 2008 Jun; 2(2):156-64. PubMed ID: 19477779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
    Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
    Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening.
    Hunter JC; Vines AI; Carlisle V
    Health Educ Behav; 2015 Aug; 42(4):539-44. PubMed ID: 25616411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Course of Patients With Prostate-Specific Antigen ≥100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening.
    Leung AK; Hugar L; Patil D; Wong L; Carthon B; Carney KJ; Birdsong G; Moses KA; Master VA
    Urology; 2018 Jul; 117():101-107. PubMed ID: 29656066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen concentration in young men: new estimates and review of the literature.
    Sutcliffe S; Pakpahan R; Sokoll LJ; Elliott DJ; Nevin RL; Cersovsky SB; Walsh PC; Platz EA
    BJU Int; 2012 Dec; 110(11):1627-35. PubMed ID: 22502603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
    Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
    J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.
    Fleshner K; Carlsson SV; Roobol MJ
    Nat Rev Urol; 2017 Jan; 14(1):26-37. PubMed ID: 27995937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.
    Dickey SL; Cormier EM; Whyte J; Graven L; Ralston PA
    Public Health Nurs; 2016 Nov; 33(6):483-492. PubMed ID: 26790837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
    Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
    J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.